Skip to main content

Table 3 CS qPCR1 application for therapy monitoring

From: Application of qPCR in conjunctival swab samples for the evaluation of canine leishmaniasis in borderline cases or disease relapse and correlation with clinical parameters

Dog ID Day* Left CS qPCR (par/5×104cells) Right CS qPCR (par/5×104cells) Left ΔCt Right ΔCt Therapy protocol
57 0 0.00 1.83 -- 4.51 Glucantime doxycycline
17 0.00 0.00 -- --
67 0 9.36 9.80 −0.25 −0.28 Miltefosine
30 0.00 1.87 -- 2.46
68 0 4.11 70.96 1.05 −3.15 Glucantime allopurinol
56 0.00 0.00 -- --
72 0 1.13 49.54 3.67 −1.77 Glucantime allopurinol
49 0.00 0.00 -- --
  1. *day 0 corresponds to initiation of therapy.